Karyopharm Therapeutics Inc (KPTI)
1.17
-0.11
(-8.59%)
USD |
NASDAQ |
Apr 19, 16:00
1.165
0.00 (0.00%)
After-Hours: 20:00
Karyopharm Therapeutics Gross Profit (TTM): 141.09M for Dec. 31, 2023
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 141.09M |
| September 30, 2023 | 140.54M |
| June 30, 2023 | 140.61M |
| March 31, 2023 | 142.96M |
| December 31, 2022 | 151.86M |
| September 30, 2022 | 245.68M |
| June 30, 2022 | 247.61M |
| March 31, 2022 | 230.33M |
| December 31, 2021 | 206.42M |
| September 30, 2021 | 114.94M |
| Date | Value |
|---|---|
| June 30, 2021 | 98.73M |
| March 31, 2021 | 110.39M |
| December 31, 2020 | 105.38M |
| September 30, 2020 | 88.03M |
| June 30, 2020 | 79.28M |
| March 31, 2020 | 55.65M |
| December 31, 2019 | 38.49M |
| September 30, 2019 | 21.99M |
| June 30, 2019 | 10.09M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
10.09M
Minimum
Jun 2019
247.61M
Maximum
Jun 2022
124.74M
Average
114.94M
Median
Sep 2021
Gross Profit (TTM) Benchmarks
| Geron Corp | -- |
| Arbutus Biopharma Corp | -- |
| Verastem Inc | -- |
| Actinium Pharmaceuticals Inc | -- |
| Chimerix Inc | 0.324M |